Vaxcyte (PCVX) total assets

Total assets · fiscal 2025
$3.00B

Vaxcyte (PCVX) had total assets of $3.00B at the end of fiscal 2025 (December 31, 2025). That is 14.5% lower than the $3.51B of fiscal 2024. Figures as of 18 Nov 2026, 04:31 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$3.00B
Change on fiscal 2024
−14.5%
Growth, 5 years
+50.2% a year
Highest on record
$3.51Bfiscal 2024
Lowest on record
$65.70Mfiscal 2019
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Vaxcyte total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 50.2% a year. Across the 7 fiscal years on record (2019–2025), the highest was $3.51B in fiscal 2024 and the lowest $65.70M in fiscal 2019.

History · 7 fiscal years

Total assets by fiscal year

Vaxcyte total assets, year by year

Vaxcyte (PCVX) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$3.00B 14.5% down
2024$3.51B 149.4% up
2023$1.41B 39.9% up
2022$1.01B 210.2% up
2021$324.34M 17.4% down
2020$392.83M 497.9% up
2019$65.70M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of Vaxcyte and comparable companies
CompanyTotal assetsFiscal year
Avantor AVTR$11.79B2025
Ensign Group ENSG$5.46B2025
Vaxcyte PCVX$3.00B2025
Bio-Rad Laboratories BIO$10.58B2025
Molina Healthcare MOH$15.56B2025
Spyre Therapeutics SYRE$777.78M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PCVX

Vaxcyte, figure by figure

Vaxcyte (PCVX) overview: price, valuation and scorecardAll health care companies by market value

Vaxcyte total assets: questions and answers

How large are Vaxcyte's total assets?

Vaxcyte (PCVX) had total assets of $3.00B at the end of fiscal 2025 (December 31, 2025). That is 14.5% lower than the $3.51B of fiscal 2024.

What is the growth rate of Vaxcyte's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 50.2% a year.

What are the highest and lowest total assets figures on record for Vaxcyte?

Across the 7 fiscal years on record (2019–2025), the highest was $3.51B in fiscal 2024 and the lowest $65.70M in fiscal 2019.

How is Vaxcyte's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vaxcyte (PCVX) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/PCVX/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.